Funder: Illumina
Due Dates (Anticipated): January 2027 (Application deadline)
Funding Amounts: One in-kind award valued at over $100,000 USD: 1,008 samples of the Infinium Methylation Screening Array-48 Kit
Summary: Supports new DNA methylation research projects that advance understanding of epigenetics, human health, and disease.
Key Information: Open to basic scientists focused on genomics at academic, for-profit, or nonprofit institutions.
Description
Illumina’s Epigenetics Research Grant is a research supply contest supporting new projects using the Infinium Methylation Screening Array-48 Kit. The program aims to deepen understanding of how epigenetics, particularly DNA methylation, affects biology and disease. It reflects Illumina’s focus on epigenetics in cellular health, development, regulation, and disease, and on providing tools for discoveries that improve understanding of human health.
The contest recognizes researchers who can advance epigenetics through scientifically sound, feasible projects that generate new knowledge. Proposals are assessed for their potential to improve scientific knowledge, technical capability, or clinical practice, alongside the applicant’s and supporting institution’s research track record. Previous recipients have investigated methylation changes associated with future Crohn’s disease risk, early Alzheimer’s disease pathology, and the effects of heart surgery and blood transfusions.
